NICE rejects breast cancer drug because too costly

NICE says the manufacturer would not lower the price sufficiently to make the drug affordable for the NHS Related items from OnMedica Cash for new cervical cancer drug New breast cancer drug ‘unaffordable’ for NHS Women may be offered drug to prevent breast cancer NICE rejects drug for advanced breast cancer Breast cancer drug everolimus fails to get NICE approval

via OnMedica News Read More Here..